Rani Therapeutics Holdings reported a net margin of -493.03% for the quarter ended Jun 2026. These financial ratios cover 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||
| EBT Margin | -1,529.38% | -7,405.81% | -581.66% | -469.26% | -493.03% | ||||||||||||||||||||
| EBIT Margin | -1,455.06% | -6,984.30% | -584.19% | -488.23% | -516.86% | ||||||||||||||||||||
| EBITDA Margin | -1,455.06% | -6,984.30% | -584.19% | -488.23% | -516.86% | ||||||||||||||||||||
| Operating Margin | -1,455.06% | -6,984.30% | -584.19% | -488.23% | -516.86% | ||||||||||||||||||||
| Net Margin | -1,529.38% | -7,405.81% | -581.66% | -469.26% | -493.03% | ||||||||||||||||||||
| FCF Margin | -844.94% | -4,767.44% | 20.12% | -381.44% | -530.15% | ||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||
| Assets AverageAssets Avg. | 107.14M | 130.58M | 119.76M | 109.83M | 106.27M | 108.11M | 102.24M | 89.98M | 76.97M | 64.18M | 55.71M | 48.62M | 43.63M | 40.09M | 30.38M | 20.51M | 13.52M | 34.38M | 55.25M | 56.36M | |||||
| Invested CapitalInvested Cap. | 132.00M | 121.69M | 110.78M | 98.68M | 100.75M | 103.21M | 90.80M | 77.43M | 64.14M | 54.82M | 43.97M | 35.05M | 34.08M | 28.11M | 15.57M | 8.08M | 1.56M | 41.51M | |||||||
| Asset Utilization RatioAsset Util. | 0.03 | 0.02 | 0.02 | 0.03 | 0.04 | 0.06 | 0.09 | 0.05 | 0.06 | 0.09 | |||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -252.55 | 0.01M | -46.43 | -24.31 | -13.68 | -14.45 | -13.57 | -10.37 | -10.85 | -9.82 | -8.82 | -13.31 | -12.74 | -11.98 | -10.01 | -24.60 | -94.76 | -0.00M | |||||||
| Debt Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.27 | 0.30 | 0.35 | 0.42 | 0.51 | 0.55 | 0.67 | 0.65 | 0.67 | 0.87 | 1.02 | 1.34 | ||||||||
| Times Interest Earned | -252.55 | 0.01M | -46.43 | -24.31 | -13.68 | -14.45 | -13.57 | -10.37 | -10.85 | -9.82 | -8.82 | -13.31 | -12.74 | -11.98 | -10.01 | -24.60 | -94.76 | -0.00M | |||||||
| Valuation | |||||||||||||||||||||||||
| Price to EarningsP/E | -30.43 | -65.96 | -47.99 | -31.80 | -29.17 | -16.78 | -15.17 | -10.96 | -5.92 | -11.85 | -10.61 | -14.39 | -9.16 | -5.00 | -5.69 | -2.87 | -4.54 | -19.32 | -16.62 | -16.89 | |||||
| Price to SalesP/S | 76.50 | 421.53 | 112.35 | 77.98 | 83.28 | ||||||||||||||||||||
| Price to BookP/B | 6.63 | 7.22 | 6.00 | 5.15 | 5.46 | 3.94 | 4.15 | 4.25 | 3.12 | 6.54 | 10.79 | 34.65 | 20.17 | 22.51 | -13.55 | -3.52 | -3.00 | 3.95 | 3.75 | 2.96 | |||||
| Enterprise Value | 823.82M | 834.32M | 613.08M | 461.45M | 490.05M | 203.17M | 267.26M | 221.01M | 120.78M | 173.22M | 157.04M | 190.50M | 114.85M | 76.38M | 60.10M | 18.44M | 27.70M | 154.03M | 96.94M | 97.60M | |||||
| EV to EBIT | -29.65 | -62.44 | -44.49 | -29.12 | -29.99 | -11.62 | -16.18 | -12.08 | -6.76 | -12.89 | -11.19 | -15.21 | -9.73 | -5.11 | -5.00 | -1.76 | -3.82 | -18.05 | -11.62 | -11.06 | |||||
| EV to EBITDA | -29.65 | -62.44 | -44.49 | -29.12 | -29.99 | -11.62 | -16.18 | -12.08 | -6.76 | -12.89 | -11.19 | -15.21 | -9.73 | -5.11 | -5.00 | -1.76 | -3.82 | -18.05 | -11.62 | -11.06 | |||||
| Market Capitalization | 873.22M | 877.62M | 663.66M | 507.79M | 472.86M | 291.52M | 255.38M | 204.49M | 108.48M | 166.50M | 156.78M | 192.30M | 116.47M | 78.64M | 72.50M | 32.24M | 35.96M | 164.15M | 133.20M | 142.25M | |||||
| Price to FCFP/FCF | -78.18 | -75.20 | -69.03 | -47.43 | -37.37 | -19.23 | -20.59 | -16.18 | -7.34 | -13.17 | -16.59 | -21.15 | -13.65 | -9.05 | -8.84 | -5.53 | -7.10 | 558.33 | -20.44 | -15.71 | |||||
| EV to FCF | -73.76 | -71.49 | -63.77 | -43.10 | -38.73 | -13.40 | -21.55 | -17.49 | -8.17 | -13.70 | -16.62 | -20.95 | -13.46 | -8.79 | -7.33 | -3.16 | -5.47 | 523.92 | -14.88 | -10.78 | |||||
| EV to CFO | -74.08 | -72.87 | -65.50 | -44.68 | -40.17 | -13.89 | -21.99 | -17.97 | -8.44 | -13.88 | -16.70 | -21.10 | -13.66 | -8.82 | -7.38 | -3.18 | -5.47 | 523.92 | -14.91 | -10.82 | |||||
| Return Ratios | |||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -1,475.26% | -1,899.12% | -3,608.87% | -1,455.06% | -6,984.30% | -4,106.25% | -3,727.75% | -584.19% | -488.23% | -516.86% | |||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -42.38% | -40.33% | -52.06% | -67.74% | -59.88% | -61.42% | -68.17% | -81.47% | -100.75% | -117.64% | -150.26% | -180.56% | -221.12% | -263.99% | -500.45% | 44,192.83% | 795.18% | -176.45% | -83.67% | -72.08% | |||||
| Return on Invested Capital [ROIC]ROIC | -661.06% | -40.71% | -51.83% | -67.77% | -59.57% | -62.32% | -81.64% | -98.93% | -111.10% | ||||||||||||||||
| Return on Assets [ROA]ROA | -42.50% | -40.65% | -51.20% | -65.37% | -55.81% | -58.62% | -64.93% | -76.77% | -92.50% | -105.78% | -118.16% | -124.49% | -125.86% | -141.15% | -179.54% | -255.50% | -352.10% | -117.43% | -64.53% | -58.28% |